Publications by authors named "Pascal Finetti"

Claim this Profile
T
The plasma nanoDSF denaturation profiles predict the presence of breast cancer.
Mathilde Guerin, Rémi Eyraud, Philippe Tsvetkov, Pascal Finetti, Alexandre Giraudo

J Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage.
Georgios Efthymiou, Eugénie Lohmann, Claudio Montenegro, Paraskevi Kousteridou, Pierre Bertrand, Pascal Finetti

Sci Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.
Chaïma Cherif, Dang Tan Nguyen, Clément Paris, Thi Khanh Le, Thibaud Sefiane, Pascal Finetti

Oncogene· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.
Thi Khanh Le, Chaïma Cherif, Kenneth Omabe, Clément Paris, François Lannes, Pascal Finetti

Mol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression-based rationale for investigating CDK4/6 inhibitors in primitive myelofibrosis.
Anne Murati, Pascal Finetti, Estelle Duprez, Jérôme Rey, Emilie Mamessier

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antisense oligonucleotide targeting the heat-shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis.
Pierre-Marie Boutanquoi, Lenny Pommerolle, Lucile Dondaine, Julie Tanguy, Pierre-Simon Bellaye, Pascal Finetti

Br J Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization.
Lan T H Phi, Yating Cheng, Yohei Funakoshi, Francois Bertucci, Pascal Finetti

Breast Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies.
Maria Kfoury, Pascal Finetti, Emilie Mamessier, François Bertucci, Renaud Sabatier

Int J Mol Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing.
Arnaud Guille, José Adélaïde, Pascal Finetti, Fabrice Andre, Daniel Birnbaum

Brief Bioinform· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization.
Alexandre de Nonneville, Elsa Kalbacher, Francesco Cannone, Arnaud Guille, José Adelaïde, Pascal Finetti

Mol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy.
François Bertucci, Arnaud Guille, Florence Lerebours, Michele Ceccarelli, Najeeb Syed, Pascal Finetti

J Transl Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational landscape of inflammatory breast cancer.
François Bertucci, Florence Lerebours, Michele Ceccarelli, Arnaud Guille, Najeeb Syed, Pascal Finetti

J Transl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma.
Richard Miallot, Virginie Millet, Anais Roger, Romain Fenouil, Catherine Tardivel, Pascal Finetti

Life Sci Alliance· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer.
Zainab Hussain, Thomas Bertran, Pascal Finetti, Eugenie Lohmann, Emilie Mamessier

Cell Commun Signal· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma.
Richard Miallot, Virginie Millet, Anais Roger, Romain Fenouil, Catherine Tardivel, Pascal Finetti

Life Sci Alliance· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.
Alice Mogenet, Pascal Finetti, Emilie Denicolai, Laurent Greillier, Pascaline Boudou-Rouquette

J Transl Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer.
François Bertucci, Alexandre De Nonneville, Pascal Finetti, Emilie Mamessier

Cancer Commun (Lond)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MonarchE trial: improving the clinical outcome in HR /HER2 early breast cancer: recent results and next steps.
François Bertucci, Pascal Finetti, Emilie Mamessier, Alexandre De Nonneville

Cancer Commun (Lond)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines.
Sandra Udu-Ituma, José Adélaïde, Thi Khanh Le, Kenneth Omabe, Pascal Finetti

Pharmaceutics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
François Bertucci, Alexandre de Nonneville, Pascal Finetti, Emilie Mamessier

J Natl Cancer Inst· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity.
Richard Miallot, Virginie Millet, Yann Groult, Angelika Modelska, Lydie Crescence, Pascal Finetti

Life Sci Alliance· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network.
Elsa Nigon, Claudia Lefeuvre-Plesse, Alejandra Martinez, Céline Chauleur, Alain Lortholary, Pascal Finetti

J Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers.
Célestin Bigarré, François Bertucci, Pascal Finetti, Gaëtan Macgrogan, Xavier Muracciole

Comput Methods Programs Biomed· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer.
Raphael Rapetti-Mauss, Jérémy Nigri, Camille Berenguier, Pascal Finetti, Sarah Simha Tubiana

Gut· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Value of Expression in Early Breast Cancer and by Molecular Subtype.
Alexandre de Nonneville, Pascal Finetti, Laurys Boudin, Emilie Denicolaï, Daniel Birnbaum

Pharmaceutics· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis